Answer
Alemtuzumab targets CD52, a cell-surface antigen present at high levels on T (CD3+) and B (CD19+) lymphocytes.
Sources for this answer
- LEMTRADA 12 mg concentrate for solution for infusionSANOFI · emc · SmPC §5.1 Pharmacodynamic properties · Version 3Document updated
Sources checked